Collection of Blood Specimens for Circulating Tumor Cell Analysis
NCT01943500 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14
Last updated 2017-02-15
Summary
Objective: To test the sensitivity of a proprietary novel filtration device designed to capture and concentrate circulating tumor cells (CTCs).
Conditions
Sponsors & Collaborators
-
Commonwealth Hematology-Oncology, P.C.
collaborator UNKNOWN -
Viatar LLC
lead INDUSTRY
Principal Investigators
-
Pedro M Sanz-Altamira, MD, PhD · Commonwealth Hematology-Oncology, P.C.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2014-01-28
- Completion
- 2016-08-26
Countries
- United States
Study Locations
More Related Trials
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
NCT01441089 ·Status: RECRUITING
-
Healthy Human Control Blood Collection for Validation of Biomarker Assay
NCT02302885 ·Status: COMPLETED
-
Collection of Biological Specimens and Associated Health Information
NCT06369441 ·Status: NOT_YET_RECRUITING
-
Collection of Blood, Bone Marrow, Tumor or Tissue Samples
NCT00043615 ·Status: COMPLETED
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069 ·Status: RECRUITING
-
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
NCT02090530 ·Status: RECRUITING
-
Liquid Biopsy Collection Study
NCT06068348 ·Status: ACTIVE_NOT_RECRUITING
-
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
NCT05600933 ·Status: ENROLLING_BY_INVITATION
-
Culture of Circulating Tumor Cells Isolated From Cancer Patients With Metastatic Disease
NCT02781025 ·Status: COMPLETED
-
Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC
NCT02436772 ·Status: COMPLETED
-
Detection of Circulating Tumor Cells in Peripheral Blood From Healthy Volunteers and Patients With Cancer
NCT02904161 ·Status: COMPLETED
-
Circulating Tumor Cells (CTC) in Cancer
NCT04520672 ·Status: RECRUITING
-
Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cells
NCT01022723 ·Status: UNKNOWN
-
Genetic Investigation of Solid Tumors Cohort
NCT01005225 ·Status: COMPLETED
-
Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer
NCT03892096 ·Status: COMPLETED
-
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202
NCT01503619 ·Status: COMPLETED
-
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
NCT00904514 ·Status: TERMINATED
-
Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)
NCT02080650 ·Status: COMPLETED ·Phase: NA
-
Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers
NCT01528774 ·Status: COMPLETED
-
Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay
NCT02586389 ·Status: RECRUITING
-
Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer
NCT00283530 ·Status: TERMINATED
-
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
NCT02474160 ·Status: RECRUITING
-
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
NCT00899496 ·Status: COMPLETED
-
Tumor-Derived FGF19
NCT06068257 ·Status: RECRUITING
-
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer
NCT00898781 ·Status: TERMINATED